The genetic testing company 23andMe filed for bankruptcy in March, after years of slowing sales, legal trouble, and a declining stock price. And now, the valuable trove of genetic data the company owns is for sale, sparking privacy concerns.

On today’s Big Take, Bloomberg biotech reporter Gerry Smith traces the rise and fall of 23andMe, and bankruptcy reporter Jonathan Randles outlines what a possible sale could mean for millions of users’ genetic data.

Read more: Bankrupt 23andMe’s DNA Data Gets Sale Nod as Concerns Linger

See omnystudio.com/listener for privacy information.

Trump announced the steepest American tariffs in more than a century, with a 10% tariff on all exporters to the US and even higher duties on some 60 nations. China now faces a tariff well above 50% on many goods.

On today’s Big Take, Bloomberg reporter Josh Wingrove joins host David Gura to discuss Trump’s “huge” announcement, and how it will reshape global trade.

Read more: Trump Tariffs Everyone, With Rate on China Set to Soar Above 50%
Further listening: The World Is Paying for Trump’s China Tariffs

See omnystudio.com/listener for privacy information.

India’s historic stock market surge sparked a retail-investing frenzy that minted millionaires. But the boom also became a breeding ground for financial scams.

On today’s Big Take Asia Podcast, host K. Oanh Ha talks to Bloomberg’s Alex Gabriel Simon about the retail investors that have been cheated out of their life savings, and how this influx of scams could undermine Prime Minister Narendra Modi’s efforts to promote his nation’s stock market to global money managers.

Read more: Scamsters Trick India's Retail Investors Out of Millions in Life Savings

Further listening: Inside Southeast Asia’s Most Notorious Crime Hub

Watch, from Originals: Is India's Stock Market a Bubble About to Burst?

See omnystudio.com/listener for privacy information.